Watch CBS News

Delta Variant

0715-cbsn-xgh-xgj-755023-640x360.jpg

New warning about COVID misinformation as cases spike

New coronavirus infections have doubled in the U.S. as the pace of vaccinations gets cut in half. As Jericka Duncan reports, the Surgeon General warns misinformation may be playing a part. Then, Dr. Shad Marvasti, a family medicine physician and the director of public health, prevention and health promotion at The University of Arizona College of Medicine in Phoenix, joins CBSN's Lana Zak to discuss the day's coronavirus headlines.

wjc-754069-640x360.jpg

Tennessee ends vaccine outreach for youth

Tennessee's Department of Public Health announced it will end vaccine outreach efforts for children and teens following pressure from conservative Republican state lawmakers. The Tennessean reports that the changes will apply to vaccines against all diseases, not just COVID-19. Amber D'Souza, epidemiology professor at the Johns Hopkins Bloomberg School of Public Health, joins "Red and Blue" anchor Elaine Quijano with more on the effectiveness of government vaccine outreach, and the lastest on the spread of the Delta variant.

cbsn-fusion-fda-warns-of-possible-link-between-jj-vaccine-and-a-rare-neurological-disorder-thumbnail-752375-640x360.jpg

FDA flags small risk of neurological disorder after J&J vaccine

Federal health officials flagged "a small possible risk" of developing a nervous system disorder after receiving Johnson and Johnson's COVID-19 vaccine on Monday, after the CDC identified a very rare pattern of Guillain-Barré syndrome in some recipients of the shot. As Nikki Battiste reports, there have been about 100 cases, mostly in older men. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University Bloomberg School of Public Health, joins CBSN to discuss vaccine concerns and a recent spike in new infections.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.